Back to Erste Asset Management GmbH Erste Asset Management GmbH

STOK

Showing 6 of 12 quarters

Position history for Erste Asset Management GmbHErste Asset Management GmbH's holdings in Stoke Therapeutics, Inc.

Yes. Erste Asset Management holds 428,381 shares of STOK (Stoke Therapeutics), worth $13.9M, as of its Q2 2026 13F filing. It reduced the position by 17,619 shares (-4.0%) from Q1 2026. Erste Asset Management has held STOK since Q1 2025, across 6 quarterly 13F filings. STOK is 0.1% of Erste Asset Management's reported 13F portfolio.

Current Value

$13.9M

Current Shares

428,381

Total Value Change

+$11.2M

Total Shares Change

+32,381

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
428,381
-4.0%
$13.9M0.1%$32.72
0
2026-Q1
Increased
446,000
+12.6%
$14.2M0.1%$32.56
38
2025-Q4
Unchanged
396,000
0.0%
$12.6M0.1%$31.74
0
2025-Q3
Unchanged
396,000
0.0%
$9.8M0.1%$23.50
0
2025-Q2
Unchanged
396,000
0.0%
$4.5M0.0%$11.35
0
2025-Q1
New
396,000
-
$2.7M0.0%$6.65
36

Other major holders of STOK: FMR LLC, RTW Investments, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used